Health Care Equipment & Services

Optomed Oyj Q4 2025 results: €4.8 M revenue, €‑1.3 M EBIT due to one‑off cost, cautious outlook, shares down amid Helsinki market dip.

Hims & Hers stock drops 70% after FDA pulls its copy‑cat weight‑loss drug and Novo Nordisk sues for patent infringement, exposing the company’s legal and growth risks.

Solventum Corp’s Q4/2025 earnings release on Feb 26, 2026 promises key insights into its $13.5 B market cap, P/E 8.86, and evolving health‑care innovation strategy.

Profusa’s Lumee launch sparks hopes, yet shares slump—see why investors stay skeptical and what the 52‑week gap reveals about future revenue prospects.

Ottobock shares stay flat at €60.85 with a 7.03 P/E, still below the 52‑week low. The German medical‑tech firm’s €3.89 bn cap signals steady value but no recent catalysts.

MedMira Inc’s rapid‑diagnostic tech faces steep financial pressure—negative earnings, volatile share price, and declining market cap—yet investors watch its next steps closely.

Spire Healthcare Group PLC’s current market outlook: stable yet volatile share price, high P/E hinting growth, and ongoing investor interest in UK healthcare.

MEDIAN Technologies SACA drives cancer care forward with AI‑powered imaging services, eyonis and iCRO, while navigating financial turbulence to stay a global oncology leader.

EssilorLuxottica’s record‑high valuation, resilient earnings, and luxury‑eyewear brand power face geopolitical and supply‑chain risks—find out if the premium is justified.

Perimeter Medical Imaging AI Inc. boosts its healthcare reach with a new partnership with Intermountain Health while navigating stock volatility and a current loss‑based valuation.